$ARWR from the top pick on polls to -37% YTD.
Twitter sentiment is mostly negative or non-existent bar a couple ppl.
Why is the co less attractive at a much lower price - with imho, good progress YTD?
I am seeing further references to CD19- plasma B cells driving many of the autoimmune diseases (e.g. SLE), and this CD19 CAR-T may not be ideal for these indications.
I am seeing further references to CD19- plasma B cells driving many of the autoimmune diseases (e.g. SLE), and this CD19 CAR-T may not be ideal for these indications.
More from @LifeSciVC on AI: I think true generative AI—coming up with brand new molecules never before seen by man, I think that remains elusive. A lot of the discovery-focused AI shops are mining patent literature and adding methyl groups here and there to existing things—and…
More from @LifeSciVC on AI: I think true generative AI—coming up with brand new molecules never before seen by man, I think that remains elusive. A lot of the discovery-focused AI shops are mining patent literature and adding methyl groups here and there to existing things—and…
901 Followers 6K FollowingValue Guy. Avid Reader. Curious. Tweets are own; I keep open mind & may change views. Tweets are NOT investment advice/recommendations. Do your own diligence.
538 Followers 4K FollowingSciinov Group welcomes you to the “GLOBAL LONGEVITY FEDERATION (GLF 2026)” HYBRID EVENT during March 23-24, 2026 in Rome, Italy
1K Followers 6K FollowingLibertarian, CPA, (shooting for CFA), interested in Markets, Trading, Austrian Economics, BioTech, Lowcarb, wannabe Trader.. Just trying to learn from you all
151 Followers 285 FollowingIn the biotech and pharmaceutical industry for 25 years. Oncology drug development. Developing ADCs, biologics and small molecules from preclinical, IND and BLA
2K Followers 540 FollowingPharmacologist and biotech trader. Focus on trading around biotech catalysts. Tweets are not investment advice. May have a position in names I tweet about.
24K Followers 8 FollowingA community project to see how AI can invest
Run in partnership with Dr. @alejandroll10 PhD from Wharton
$40M+ invested alongside via @joinautopilot_
518 Followers 190 FollowingI don't always write about companies that I favor | Strategy is much important | Mainly healthcare related | Not Investment Advice
313K Followers 4K FollowingThese posts were issued before my FDA employment and do not necessarily represent the views of the FDA or the United States. The account is now inactive.
797 Followers 598 FollowingCo-founder of Sanoosa. Computational methods to discover and design novel molecules for medicines. Likes are Likes. @wkissel.bsky.social
30K Followers 989 FollowingCEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
16K Followers 506 FollowingGene editor + Professor Molecular Therapeutics @berkeleyMCB + Director for Technology and Translation @igisci + @danahercorp Beacon for CRISPR Cures.
2K Followers 142 FollowingWe write a newsletter focused on micro/small-cap healthcare cos. Comments are not investment advice. Sometimes we get paid. Disclosures at https://t.co/k7TK1zioAS
2.6M Followers 3K FollowingResearch, News, and Commentary from Nature, the international science journal
For daily science news, get Nature Briefing: https://t.co/wGmQlQ8a4D